With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...
With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...
Eli Lilly announces $15 billion share buyback plan and 15% dividend boost amidst mixed technical signals. Investors are ...
Eli Lilly and Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
According to the announcement, the share repurchase program allows for flexibility in purchasing methods, including open ...
One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...
Eli Lilly and Company LLY announced that its board of directors approved a new $15 billion share buyback plan. The earlier $5 ...
Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive ...
Nvidia was falling early on Tuesday as it faces an antitrust investigation in China, despite a sales boost from key supplier ...
The Virco Mfg. Corporation ( NASDAQ:VIRC ) share price has had a bad week, falling 19%. But that doesn't change ...
Suspect in C.E.O.’s Killing Fights Extradition to New York Police say suspect in the United Healthcare killing saw himself as a hero fighting corruption. The suspect had discussed a series of ...